ABL Medical

ABL Medical markets, sells, and distributes the antibacterial wound dressing gel SilvrSTAT. SilvrSTAT is a multivalent catalytic nanoparticulate molecular silver technology. It provides a new generation of wound care and in laboratory tests has been shown to inhibit the growth of microorganisms, bacteria, antibiotic-resistant strains as well as fungi. SilvrSTAT wound dressing gel is indicated for management of select burns, ulcers, skin tears and donor, graft, insertion and incision sites. It provides superior wound management without any known or suspected adverse reactions

Abl medical operates in the Medical equipment manufacturing industry.

Abl medical's revenue is 11m - 100m

Abl medical has 11 - 50 employees.